EUVIMEDDescoperă EUVIMED
Open access · CC BY 4.0

Clinical Value of Various Histological Factors in Cutaneous and Subcutaneous Mast Cell Tumors in 197 Dogs

Katherine Boyd iD, Melanie Dobromylskyj, Imogen Schofield, Dan O'Neill, Celia Figueroa, Owen Davies

Journal of Veterinary Internal Medicine · 2025-11-01 · 39 (6)

DOI: 10.1111/jvim.70244 ↗

At a glance

Journal article in Journal of Veterinary Internal Medicine, published online on 2025-11-01. Written by Katherine Boyd and 5 co-authors. Institution: Bristol Vet Specialists, Bristol, UK. Major MEDLINE topics: Dog Diseases, Skin Neoplasms. Cited 2 times so far (Crossref); 60 references. The full text is freely available (open access, CC BY 4.0).

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background

Many histological tests have been correlated with outcome in mast cell tumors (MCTs)in dogs, but their statistical independence is uncertain.

Objective

To investigate the clinical value of histological factors in the prognostication of dogs with MCTs. Animals One hundred and ninety-seven dogs with 199 histologically diagnosed cutaneous (n = 153) and subcutaneous (n = 43) MCTs treated surgically in primary care practice. All had a commercial prognostic panel performed (Patnaik and Kiupel grade, mitotic count, Ki67, AgNOR, KiAg, c-kit mutation in exons 8 and 11 and KIT localization).

Methods

Retrospective cohort study identifying dogs from searching a commercial laboratory's records (January 2017–August 2020). Follow-up was collected from clinical records. Outcome measures included MCT specific survival (MSS) and recurrence.

Results

Multivariable Cox proportional hazard regression identified only mitotic count > 5 (HR 10.2; 95% CI 3.2–32.8; p < 0.001) predicted poorer MSS across all MCTs. In Patnaik grade I or II and Kiupel low-grade cutaneous MCTs, only c-kit mutation in exon 11 (HR 20.8; 95% CI 1.80–224.8; p = 0.015) predicted MSS. A c-kit mutation in exon 11 (HR 10.0; 95% CI 3.0–32.9; p < 0.001), age, and histological tumor free margins < 2 mm independently predicted cutaneous and subcutaneous MCT recurrence. In Patnaik grade I or II, and Kiupel low-grade cutaneous MCTs, c-kit mutation in exon 11 (HR 23.20; 95% CI 2.3–231.3; p = 0.007) and AgNOR (HR 13.73; 95% CI 1.6–115.6; p = 0.016) predicted MCT recurrence. Conclusion and Clinical Importance This study suggests a comparatively greater role of c-kit mutations in exon 11 and AgNOR in the prognostication of MCTs, while Ki67 appears less important.

Subjects

MeSH terms (MEDLINE)

Dog DiseasesSkin NeoplasmsDogsAnimalsRetrospective StudiesFemaleMalePrognosisProto-Oncogene Proteins c-kitMutationNeoplasm Recurrence, Local

Author keywords

c‐kitAgNORKIT stainingKi67MCTcaninemarginsmitotic countrecurrencetumor

Substances

Proto-Oncogene Proteins c-kit

Authors and institutions

  • Bristol Vet Specialists, Bristol, UK.
  • Finn Pathologists, Norfolk, UK.
  • CVS, Norfolk, UK.
  • Royal Veterinary College, London, UK.
  • The Ralph Veterinary Referral Centre, Marlow, UK.

ORCID profiles: Katherine Boyd

Cite

APA

Boyd, K., Dobromylskyj, M., Schofield, I., O'Neill, D., Figueroa, C., & Davies, O. (2025). Clinical Value of Various Histological Factors in Cutaneous and Subcutaneous Mast Cell Tumors in 197 Dogs. Journal of Veterinary Internal Medicine, 39(6). https://doi.org/10.1111/jvim.70244

Vancouver

Boyd K, Dobromylskyj M, Schofield I, O'Neill D, Figueroa C, Davies O. Clinical Value of Various Histological Factors in Cutaneous and Subcutaneous Mast Cell Tumors in 197 Dogs. Journal of Veterinary Internal Medicine. 2025;39(6). doi:10.1111/jvim.70244

BibTeX
@article{Boyd2025,
  author = {Boyd, Katherine and Dobromylskyj, Melanie and Schofield, Imogen and O'Neill, Dan and Figueroa, Celia and Davies, Owen},
  title = {Clinical Value of Various Histological Factors in Cutaneous and Subcutaneous Mast Cell Tumors in 197 Dogs},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2025},
  volume = {39},
  number = {6},
  doi = {10.1111/jvim.70244}
}
Start for free →